Skip to main content
. 2020 Oct 15;28(1):327–332. doi: 10.1016/j.sjbs.2020.10.006

Table 1.

Group allocation for the hepatoprotective study.

Groups Drug Administered
1 Negative Control
2 Toxic Control; CCl4(2 mL/kg, Intraperitonially, in Olive Oil)
3 Positive Control; Silymarin (Orally)
4 BB-160 (Orally)
5 BB-APSP-40 (Orally)
6 BB-APSP-80 (Orally)

BB = Berberine, BB-APSP = Berberine nanoparticles prepared by antisolvent method.